The authors conducted an immunohistochemical study for markers such as GLUT1 and GLUT3 and reported that, unlike GLUT3 (expressed in all the lesions analyzed), GLUT1 was downregulated in 55% of primary melanomas, suggesting that glucose transport occurred across the plasma membrane by other transporters [16]. The gene discussed is SLC2A1; the disease is melanoma.